Thus, the sustained release of anti-PD-L1 antibody and D-1MT in vivo resulted in effective T cell-mediated immune responses through the elevated presence of tumor-infiltrating CD45+ and CD8+ T cells in the TME of collected tumor tissues. The gene discussed is CD274; the disease is neoplasm.